Evidence map›Paper›PMID 25556372›Full record

ArticleMolecules and cells2015

MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1.

Zhen Liang, Shiqi Li, Xin Xu, Xianglai Xu, Xiao Wang, Jian Wu, Yi Zhu, Zhenghui Hu, Yiwei Lin, Yeqing Mao and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Molecules and cells, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The role of microRNAs in bladder cancer.Investigative and clinical urology · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Zhen LiangDepartment of Urology, the First Affiliated Hospital, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.
Shiqi LiDepartment of Urology, the First Affiliated Hospital, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.
Xin XuDepartment of Urology, the First Affiliated Hospital, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.
Xianglai XuDepartment of Urology, the First Affiliated Hospital, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.
Xiao WangDepartment of Urology, the First Affiliated Hospital, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.
Jian WuDepartment of Urology, the First Affiliated Hospital, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.
Yi ZhuDepartment of Urology, the First Affiliated Hospital, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.
Zhenghui HuDepartment of Urology, the First Affiliated Hospital, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.
Yiwei LinDepartment of Urology, the First Affiliated Hospital, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.
Yeqing MaoDepartment of Urology, the First Affiliated Hospital, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.
Hong ChenDepartment of Urology, the First Affiliated Hospital, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.
Jindan LuoDepartment of Urology, the First Affiliated Hospital, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.
Ben LiuDepartment of Urology, the First Affiliated Hospital, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.
Xiangyi ZhengDepartment of Urology, the First Affiliated Hospital, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.
Liping XieDepartment of Urology, the First Affiliated Hospital, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.
First Affiliated Hospital Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are small, endogenous RNAs that play important gene-regulatory roles by binding to the imperfectly complementary sequences at the 3'-UTR of mRNAs and directing their gene expression. Here, we first discovered that miR-576-3p was down-regulated in human bladder cancer cell lines compared with the non-malignant cell line. To better characterize the role of miR-576-3p in bladder cancer cells, we over-expressed or down-regulated miR-576-3p in bladder cancer cells by transfecting with chemically synthesized mimic or inhibitor. The overexpression of miR-576-3p remarkably inhibited cell proliferation via G1-phase arrest, and decreased both mRNA and protein levels of cyclin D1 which played a key role in G1/S phase transition. The knock-down of miR-576-3p significantly promoted the proliferation of bladder cancer cells by accelerating the progression of cell cycle and increased the expression of cyclin D1. Moreover, the dual-luciferase reporter assays indicated that miR-576-3p could directly target cyclin D1 through binding its 3'-UTR. All the results demonstrated that miR-576-3p might be a novel suppressor of bladder cancer cell proliferation through targeting cyclin D1.

Indexed as

3' Untranslated RegionsCell Line, TumorCell ProliferationCyclin D1Down-RegulationG1 Phase Cell Cycle CheckpointsGene Expression Regulation, NeoplasticHumansMicroRNAsUrinary Bladder Neoplasms3' Untranslated RegionsCCND1 protein, humanCyclin D1MicroRNAsMIRN576 microRNA, humanbladder cancercyclin D1microRNA-576-3pproliferation

Identifiers

PMID25556372
PMCPMC4332027
OpenAlexW2160215917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.